CL2019002552A1 - Composition for the measurement, prevention or relief of skin aging using hapln1. - Google Patents

Composition for the measurement, prevention or relief of skin aging using hapln1.

Info

Publication number
CL2019002552A1
CL2019002552A1 CL2019002552A CL2019002552A CL2019002552A1 CL 2019002552 A1 CL2019002552 A1 CL 2019002552A1 CL 2019002552 A CL2019002552 A CL 2019002552A CL 2019002552 A CL2019002552 A CL 2019002552A CL 2019002552 A1 CL2019002552 A1 CL 2019002552A1
Authority
CL
Chile
Prior art keywords
hapln1
aging
skin
composition
expression
Prior art date
Application number
CL2019002552A
Other languages
Spanish (es)
Inventor
Moon Jung Back
Dae Kyong Kim
Zhicheng Fu
Original Assignee
Haplnscience Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haplnscience Inc filed Critical Haplnscience Inc
Priority to CL2019002552A priority Critical patent/CL2019002552A1/en
Publication of CL2019002552A1 publication Critical patent/CL2019002552A1/en

Links

Abstract

LA PRESENTE DIVULGACIÓN SE REFIERE A PROTEÍNA HAPLN1 DE UN INDIVIDUO ENVEJECIDO. LA PROTEÍNA HAPLN1 PRESENTA EXPRESIÓN REDUCIDA CON EL ENVEJECIMIENTO, Y CUANDO SE ADMINISTRA, ES EXCELENTE SU EFECTO EN ALIVIAR Y REVERTIR EL ENVEJECIMIENTO DE LA PIEL INCLUYENDO ARRUGAS. POR TANTO, EXPLOTANDO LA DIFERENCIA EN LA EXPRESIÓN, SE PROPORCIONAN UNA COMPOSICIÓN DE BIOMARCADOR PARA MEDIR EL ENVEJECIMIENTO DE LA PIEL, CAPAZ DE DIAGNOSTICAR EL ENVEJECIMIENTO DE LA PIEL; UN KIT; Y UN MÉTODO DE BÚSQUEDA DE AGENTES DE ALIVIO DEL ENVEJECIMIENTO DE LA PIEL, QUE COMPRENDE DETECTAR EL NIVEL DE EXPRESIÓN DE PROTEÍNA HAPLN1 O GEN HAPLN1. ADEMÁS, SE PROPORCIONAN UNA COMPOSICIÓN FARMACÉUTICA, COMPOSICIÓN COSMÉTICA, O NUTRACÉUTICO, PARA PREVENIR O ALIVIAR EL ENVEJECIMIENTO DE LA PIEL, Y UNA COMPOSICIÓN COSMÉTICA O NUTRACÉUTICO PARA ALIVIAR ARRUGAS, CONTENIENDO CADA UNO UNA CUALQUIERA O MÁS SELECCIONADOS DEL GRUPO QUE CONSISTE EN PROTEÍNA HAPLN1, UN GEN QUE CODIFICA LA MISMA, Y UN AGENTE EFICAZ PARA PROMOVER LA EXPRESIÓN O ACTIVACIÓN DE LAS FUNCIONES DE PROTEÍNA O GEN HAPLN1.THIS DISCLOSURE REFERS TO HAPLN1 PROTEIN FROM AN AGED INDIVIDUAL. HAPLN1 PROTEIN EXPRESSES REDUCED EXPRESSION WITH AGING, AND WHEN ADMINISTERED, ITS EFFECT IN RELIEVING AND REVERSING SKIN AGING, INCLUDING WRINKLES, IS EXCELLENT. THEREFORE, EXPLOITING THE DIFFERENCE IN EXPRESSION, A BIOMARKER COMPOSITION IS PROVIDED TO MEASURE THE AGING OF THE SKIN, CAPABLE OF DIAGNOSING THE AGING OF THE SKIN; ONE KIT; AND A SEARCH METHOD FOR SKIN AGING RELIEF AGENTS, WHICH INCLUDES DETECTING THE LEVEL OF EXPRESSION OF HAPLN1 PROTEIN OR HAPLN1 GENE. IN ADDITION, A PHARMACEUTICAL COMPOSITION, COSMETIC OR NUTRACEUTIC COMPOSITION ARE PROVIDED TO PREVENT OR RELIEVE AGING OF THE SKIN, AND A COSMETIC OR NUTRACEUTIC COMPOSITION TO RELIEVE WRINKLES, CONTAINING MORE OF THE SELECTIVE PROBLEMS, CONTAINING IN EACH PROVIDED ONE A GENE THAT CODES THE SAME, AND AN EFFECTIVE AGENT TO PROMOTE THE EXPRESSION OR ACTIVATION OF THE FUNCTIONS OF PROTEIN OR HAPLN1 GENE.

CL2019002552A 2019-09-05 2019-09-05 Composition for the measurement, prevention or relief of skin aging using hapln1. CL2019002552A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CL2019002552A CL2019002552A1 (en) 2019-09-05 2019-09-05 Composition for the measurement, prevention or relief of skin aging using hapln1.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2019002552A CL2019002552A1 (en) 2019-09-05 2019-09-05 Composition for the measurement, prevention or relief of skin aging using hapln1.

Publications (1)

Publication Number Publication Date
CL2019002552A1 true CL2019002552A1 (en) 2020-01-03

Family

ID=69227777

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2019002552A CL2019002552A1 (en) 2019-09-05 2019-09-05 Composition for the measurement, prevention or relief of skin aging using hapln1.

Country Status (1)

Country Link
CL (1) CL2019002552A1 (en)

Similar Documents

Publication Publication Date Title
Salzer et al. Cathelicidin peptide LL-37 increases UVB-triggered inflammasome activation: possible implications for rosacea
CO2020009625A2 (en) Fap inhibitor
BR112016024424A2 (en) flexible rendering based on a rendering target in graphic rendering
BR122020006907B8 (en) ANTI-KRAS SINGLE DOMAIN ANTIBODY AND ITS USE, IN VITRO METHODS FOR MEASURING SAID ANTIBODY LEVELS AND FOR DIAGNOSING A DISORDER MEDIATED BY AN INTRACELLULAR COMPONENT, ISOLATED POLYPEPTIDE, AND COMPOSITION COMPRISING SUCH ANTIBODY OR ISOLATED POLYPEPTIDE
CO2018009434A2 (en) Dengue anti-virus ns1 protein monoclonal antibodies
CL2019000586A1 (en) Compositions of non-protein clostridial toxins.
BR112018069849A2 (en) kit, device and method for the detection of early pancreatic cancer or pancreatic cancer precursor lesion
BR112016012968A2 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH AGING
PE20170140A1 (en) METHODS FOR TREATING CANCER WITH TIGIT INHIBITORS AND AGENTS AGAINST CANCER
BR112018005770A2 (en) dynamic switching between late depth test and conservative depth test
CO2019009796A2 (en) Composition for the measurement, prevention or relief of skin aging using hapln1
BR112018073460A2 (en) combined therapies using farnesoid x receptor (fxr) modulators
BR112017023391A2 (en) "composition, method for preparing a composition and methods for improving skin hydration"
MX2020004837A (en) Adenosine pathway inhibitors for cancer treatment.
BR112018006349A2 (en) pixel block level granularity graphics processing unit preemption
CR20150603A (en) METALOPROTEINASE OF THE MATRIX AND USES OF THE SAME
AR105350A1 (en) CLEANING COMPOSITION WITH PROPELLENT
Shiba et al. Differential roles of MMP-9 in early and late stages of dystrophic muscles in a mouse model of Duchenne muscular dystrophy
AR102037A1 (en) PROCESSOR AND METHOD FOR THE PROCESSING OF AN AUDIO SIGNAL BY THE USE OF THE TRUNCATED ANALYSIS OR THE SOLUTION PORTIONS OF THE SYNTHESIS WINDOW
BR112017004883A2 (en) rgma fragment-based diagnostic assay
BR112018073355A2 (en) fat and its medical uses
CL2014001150A1 (en) System and method where the system is particularly a mobile device, for the determination of solute concentration in a colored liquid sample, which is based on obtaining images of the sample and known concentration patterns of the solute, and determining of the concentration of the sample based on the processing of these images and the color values that they provide
CO2020008863A2 (en) Biomarkers of immune tolerance induced by methotrexate
CL2019002552A1 (en) Composition for the measurement, prevention or relief of skin aging using hapln1.
BR112019003688A2 (en) formulations for edible bubble solution